Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $54.0B |
| FY2017, ended Dec 31, 2017 | $64.7B |
| FY2018, ended Dec 31, 2018 | $72.4B |
| FY2019, ended Dec 31, 2019 | $107B |
| FY2020, ended Dec 31, 2020 | $158B |
| FY2021, ended Dec 31, 2021 | $235B |
| FY2022, ended Dec 31, 2022 | $193B |
| FY2023, ended Dec 31, 2023 | $171B |
| FY2024, ended Dec 31, 2024 | $164B |
| FY2025, ended Dec 31, 2025 | $162B |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $158B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $16.9B |
| FY2017, ended Dec 31, 2017 | $18.3B |
| FY2018, ended Dec 31, 2018 | $19.9B |
| FY2019, ended Dec 31, 2019 | $17.9B |
| FY2020, ended Dec 31, 2020 | $22.3B |
| FY2021, ended Dec 31, 2021 | $24.8B |
| FY2022, ended Dec 31, 2022 | $26.6B |
| FY2023, ended Dec 31, 2023 | $23.9B |
| FY2024, ended Dec 31, 2024 | $23.9B |
| FY2025, ended Dec 31, 2025 | $24.6B |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $25.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.55B | $2.93B |
| FY2017, ended Dec 31, 2017 | $2.49B | $2.91B |
| FY2018, ended Dec 31, 2018 | $2.65B | $3.44B |
| FY2019, ended Dec 31, 2019 | $3.01B | $3.32B |
| FY2020, ended Dec 31, 2020 | $3.65B | $5.42B |
| FY2021, ended Dec 31, 2021 | $6.43B | $7.12B |
| FY2022, ended Dec 31, 2022 | $7.21B | $7.40B |
| FY2023, ended Dec 31, 2023 | $4.76B | $5.78B |
| FY2024, ended Dec 31, 2024 | $3.90B | $5.30B |
| FY2025, ended Dec 31, 2025 | $3.61B | $5.26B |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $4.33B | $5.73B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $964M |
| FY2017, ended Dec 31, 2017 | $630M |
| FY2018, ended Dec 31, 2018 | $788M |
| FY2019, ended Dec 31, 2019 | $19.9B |
| FY2020, ended Dec 31, 2020 | $6.04B |
| FY2021, ended Dec 31, 2021 | $2.59B |
| FY2022, ended Dec 31, 2022 | $6.00B |
| FY2023, ended Dec 31, 2023 | $5.86B |
| FY2024, ended Dec 31, 2024 | $2.08B |
| FY2025, ended Dec 31, 2025 | $4.62B |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $5.68B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $12.3B |
| FY2017, ended Dec 31, 2017 | $10.5B |
| FY2018, ended Dec 31, 2018 | $9.74B |
| FY2019, ended Dec 31, 2019 | $21.7B |
| FY2020, ended Dec 31, 2020 | $21.2B |
| FY2021, ended Dec 31, 2021 | $22.2B |
| FY2022, ended Dec 31, 2022 | $19.7B |
| FY2023, ended Dec 31, 2023 | $18.4B |
| FY2024, ended Dec 31, 2024 | $16.0B |
| FY2025, ended Dec 31, 2025 | $18.4B |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $26.5B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 1.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 693M |
| FY2017, ended Dec 31, 2017 | 698M |
| FY2018, ended Dec 31, 2018 | 702M |
| FY2019, ended Dec 31, 2019 | 696M |
| FY2020, ended Dec 31, 2020 | 712M |
| FY2021, ended Dec 31, 2021 | 715M |
| FY2022, ended Dec 31, 2022 | 729M |
| FY2023, ended Dec 31, 2023 | 740M |
| FY2024, ended Dec 31, 2024 | 715M |
| FY2025, ended Dec 31, 2025 | 707M |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | 704M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | — | $130M | $165M |
| FY2017, ended Dec 31, 2017 | — | $127M | $0 |
| FY2018, ended Dec 31, 2018 | — | $138M | $0 |
| FY2019, ended Dec 31, 2019 | — | $159M | $1.44B |
| FY2020, ended Dec 31, 2020 | — | $187M | $1.73B |
| FY2021, ended Dec 31, 2021 | — | $184M | $0 |
| FY2022, ended Dec 31, 2022 | $0 | $295M | $0 |
| FY2023, ended Dec 31, 2023 | $0 | $306M | — |
| FY2024, ended Dec 31, 2024 | $5.98B | $288M | — |
| FY2025, ended Dec 31, 2025 | $3.09B | $298M | — |
| Trailing 12 months to Sep 25, 2026 (through Q3 FY2026) | $894M | $329M | — |
Valuation
At current price- Market Cap
- $163B
- P/E
- 37.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.4×
- Price / Book
- 3.0×
- EV / EBITDA
- 23.4×
Growth
Trailing 12 months- Revenue (TTM)
- $25.6B
- Revenue Growth YoY
- 5.5%
- Revenue CAGR 3Y
- −2.7%
- Revenue CAGR 5Y
- 2.0%
- EPS Growth YoY
- 25.5%
- Net Income Growth YoY
- 23.6%
Profitability
Trailing 12 months- Gross Margin
- 58.6%
- Operating Margin
- 20.4%
- Net Margin
- 16.9%
- FCF Margin
- 22.4%
- Return on Equity
- 8.3%
Earnings
Trailing 12 months- Net Income
- $4.33B
- EPS (diluted)
- $6.10
- EBITDA
- $7.85B
- Operating Income
- $5.22B
Balance Sheet
As of Sep 25, 2026- Cash and cash equivalents
- $5.68B
- Total Debt
- $26.5B
- Net Debt
- $20.8B
- Total Assets
- $93.3B
- Total Liabilities
- $39.6B
- Shareholders' Equity
- $53.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $6.86B
- Capital Expenditure
- $1.13B
- Free Cash Flow
- $5.73B
Dividends and risk
Last 12 months- Dividend Yield
- 0.7%
- Dividend / Share
- $1.52
- Beta (5Y)
- 0.77
Every ratio is calculated from the company’s reported figures.